Literature DB >> 18220322

ALK-positive diffuse large B-cell lymphoma: report of three cases.

Hyoun Wook Lee1, Kihyun Kim, Wonseog Kim, Young Hyeh Ko.   

Abstract

Diffuse large B-cell lymphoma positive for anaplastic lymphoma kinase (ALK(+) DLBCL) is a rare variant of diffuse large B-cell lymphoma, with characteristic morphological, immunohistochemical and cytogenetic features. Only 34 cases of ALK-positive diffuse large B-cell lymphoma have so far been reported in the literature. We examined three new cases, which showed similar characteristics to previously reported cases, but with peculiar nuclear-membrane staining for ALK protein in one patient and a 5'-ALK gene deletion in another. All of them had stage IV disease at initial presentation, with poor outcomes. The tumour cells showed immunoblastic/plasmablastic histology and were positive for ALK and Oct2, but negative for CD3, CD20, CD79a, CD30 and PAX5. The staining pattern of ALK protein was cytoplasmic in two patients and associated with the nuclear membrane in one patient. Fluorescence in situ hybridization (FISH) analysis using the ALK break-apart probe revealed ALK gene rearrangements in all three patients, with a 5'-ALK gene deletion in one patient. These three cases suggest that different types of cytogenetic aberrations may involve the ALK gene in ALK-positive diffuse large B-cell lymphoma leading to peculiar immunohistochemical staining patterns.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18220322     DOI: 10.1002/hon.841

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  13 in total

1.  Novel CD19 expression in a peripheral T cell lymphoma: A flow cytometry case report with morphologic correlation.

Authors:  Kathryn Rizzo; Maryalice Stetler-Stevenson; Wyndham Wilson; Constance M Yuan
Journal:  Cytometry B Clin Cytom       Date:  2009-03       Impact factor: 3.058

2.  ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusions.

Authors:  Katrien Van Roosbroeck; Jan Cools; Daan Dierickx; José Thomas; Peter Vandenberghe; Michel Stul; Jan Delabie; Chris De Wolf-Peeters; Peter Marynen; Iwona Wlodarska
Journal:  Haematologica       Date:  2010-03       Impact factor: 9.941

Review 3.  ALK-immunoreactive neoplasms.

Authors:  Parham Minoo; Huan-You Wang
Journal:  Int J Clin Exp Pathol       Date:  2012-05-23

4.  Anaplastic lymphoma kinase-positive large B-cell lymphoma: a distinct clinicopathological entity.

Authors:  Shiyong Li
Journal:  Int J Clin Exp Pathol       Date:  2009-03-13

Review 5.  Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology.

Authors:  Bengt Hallberg; Ruth H Palmer
Journal:  Nat Rev Cancer       Date:  2013-10       Impact factor: 60.716

6.  Clinical Significance of ALK-1 Gene Abnormalities in Diffuse Large Cell Lymphoma.

Authors:  L Korashy; H El-Zawahry; S Abdou; D Shahin; F Sherif; W Farrag; O Abdel-Khalik; H Salem; A El-Sebaaie
Journal:  Clin Med Insights Oncol       Date:  2012-11-26

7.  Anaplastic lymphoma kinase-positive large B-cell lymphoma: an underrecognized aggressive lymphoma.

Authors:  Elizabeth A Morgan; Alessandra F Nascimento
Journal:  Adv Hematol       Date:  2012-02-26

Review 8.  Anaplastic lymphoma kinase: signalling in development and disease.

Authors:  Ruth H Palmer; Emma Vernersson; Caroline Grabbe; Bengt Hallberg
Journal:  Biochem J       Date:  2009-05-27       Impact factor: 3.857

Review 9.  ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature.

Authors:  Brady Beltran; Jorge Castillo; Renzo Salas; Pilar Quiñones; Domingo Morales; Fernando Hurtado; Luis Riva; Eric Winer
Journal:  J Hematol Oncol       Date:  2009-02-27       Impact factor: 17.388

10.  ALK-positive diffuse large B-cell lymphoma of the duodenum: A case report and review of the literature.

Authors:  Xiaoming Xing; Dongliang Lin; Wenwen Ran; Huamin Liu
Journal:  Exp Ther Med       Date:  2014-06-16       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.